EOS Gets Additional FDA OK for Lower Limb Imaging

EOS Imaging has received FDA clearance of its sterEOS three-dimensional (3-D) orthopedic imaging workstation for use in lower limbs applications for patients 15 years and older.
 
For decades, radiologists, orthopedic surgeons and rheumatologists have had to rely on a set of two-dimensional X-ray images to help them imagine what a 3-D skeletal image of their patients would look like. Now, according to EOS, the company’s new workstation scan create a 3-D rendering of a patient’s skeletal anatomy within seconds. Officials said the system can deliver a large 3-D, weight-bearing image at an irradiation level that is more than 100 times lower than that of a 3-D CT scan, designed to enable superior pre- and post-op surgical planning.
 
 “We are very pleased with this additional FDA clearance, as it will further fuel the market penetration momentum that we are achieving in the United States for our ultra-low-radiation-dose EOS orthopedic imaging system,” said Hervé Legrand, vice president of sales and marketing in North America for EOS imaging. “Some of the most prestigious orthopedic centers in the world, such as Barnes-Jewish Hospital (St. Louis, Mo.), New York University (N.Y.), and the University of Iowa (Iowa City), have recently adopted EOS and sterEOS for their musculoskeletal imaging suites.”
 
EOS allows full-body imaging of patients that enables global assessment of balance and posture as well as a 3-D bone-envelope image in a weight-bearing position, and provides automatically over 100 clinical parameters to the orthopedic surgeon for pre- and post-operative surgical planning.
 
The company is based in Cambridge, Mass.